1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hong Kong Pharmaceuticals and Healthcare Report Q4 2015

Hong Kong Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 113 pages

Includes 3 FREE quarterly updates

BMI View: Hong Kong's strong reliance on the public health sector will continue to place a strain on the government's budget. This is especially critical in light of its ageing population. We maintain that health expenditure in Hong Kong will continue to shift towards private expenditure and the private sector.

Headline Expenditure Projections

- Pharmaceuticals: HKD12.07bn (USD1.56bn) in 2014 to HKD12.96bn (USD1.67bn) in 2015; +7.2% in local currency and 7.1% US dollars terms. Forecast unchanged from previous quarter.
- Healthcare: HKD132.71bn (USD17.11bn) in 2014 to HKD143.45bn (USD18.46bn) in 2015; +8.1% in local currency and 7.9% in US dollars terms. Forecast unchanged from previous quarter.

Table Of Contents

Hong Kong Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political SWOT 11
Economic SWOT 12
Operational Risk SWOT 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2011-2019) 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2011-2019) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2013-2019) 33
Key Risks To BMI's Forecast Scenario 34
Macroeconomic Forecasts 35
Economic Analysis 35
Table: Economic Activity (Hong Kong 2010-2019) 39
Industry Risk Reward Index 40
Asia Pacific Risk/Reward - Q4 2015 40
Hong Kong Risk/Reward Index 46
Rewards 46
Risks 46
Market Overview 48
Industry Trends And Developments 49
Epidemiology 49
Table: Top Causes Of Deaths In Hong Kong 51
Healthcare Sector 52
Table: Healthcare Resources (Hong Kong 2009-2014) 54
Table: Healthcare Personnel (Hong Kong 2009-2014) 54
Table: Healthcare Activity (Hong Kong 2009-2014) 55
Healthcare Financing 56
Biotechnology 59
Clinical Trials 63
Regulatory Development 65
Regulatory Regime 65
Table: Processed Applications 66
Regulatory Developments 67
Pharmaceutical Trade Regulations 68
Intellectual Property Issues 68
Counterfeit Drugs 69
Pricing And Reimbursement Regime 70
Table: Number Of Drugs In Drug Formulary 71
Competitive Landscape 73
Pharmaceutical Industry 73
Traditional Chinese Medicine 74
Industry Developments 75
Pharmaceutical Supply Chain 75
Retail Pharmacy Sector 76
Company Profile 78
Wuyi International Pharmaceutical 78
CK Life Sciences 81
South Asia Pharmamedic 85
Vida Laboratories 86
GlaxoSmithKline 88
Pfizer 91
Sanofi 94
Merck and Co 97
Novartis 99
Demographic Forecast 102
Table: Population Headline Indicators (Hong Kong 1990-2025) 103
Table: Key Population Ratios (Hong Kong 1990-2025) 103
Table: Urban/Rural Population And Life Expectancy (Hong Kong 1990-2025) 104
Table: Population By Age Group (Hong Kong 1990-2025) 104
Table: Population By Age Group % (Hong Kong 1990-2025) 105
Glossary 107
Methodology 109
Pharmaceutical Expenditure Forecast Model 109
Healthcare Expenditure Forecast Model 109
Notes On Methodology 110
Risk/Reward Index Methodology 111
Index Overview 112
Table: Pharmaceutical Risk/Reward Index Indicators 112
Indicator Weightings 113

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.